{"filing":{"accession_number":"0001832928-26-000010","cik":"0001832928","ticker":"CRLBF","company_name":"Cresco Labs Inc.","form":"6-K","filing_date":"2026-08-06","report_date":"2026-06-30","primary_document":"q22026form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1832928/000183292826000010/q22026form6-k.htm"},"events":[{"id":25990,"run_id":23602,"accession_number":"0001832928-26-000010","anchor_item_number":"EX-99.3","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a quarterly earnings press release disclosing Q2 2026 financial results for Cresco Labs Inc., including revenue of $173 million, net income of $15 million, and Adjusted EBITDA of $40 million. The document explicitly states \"Cresco Labs Reports Second Quarter 2026 Financial Results\" and includes consolidated financial statements, cash flow data, and non-GAAP reconciliations typical of an earnings announcement. While the exhibit also mentions a CFO departure (Sharon Schuler stepping down), the primary and dominant disclosure is the quarterly financial results, making this an earnings_release event.","company_name":"Cresco Labs Inc.","ticker":"CRLBF","filing_date":"2026-08-06","form":"6-K","submitted_at":null,"items":[{"id":26957,"accession_number":"0001832928-26-000010","item_number":"EX-99.3","item_title":"q22026pressrelease.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a quarterly earnings press release disclosing Q2 2026 financial results for Cresco Labs Inc., including revenue of $173 million, net income of $15 million, and Adjusted EBITDA of $40 million. The document explicitly states \"Cresco Labs Reports Second Quarter 2026 Financial Results\" and includes consolidated financial statements, cash flow data, and non-GAAP reconciliations typical of an earnings announcement. While the exhibit also mentions a CFO departure (Sharon Schuler stepping down), the primary and dominant disclosure is the quarterly financial results, making this an earnings_release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:53:09.407530+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26955,"accession_number":"0001832928-26-000010","item_number":"EX-99.1","item_title":"q22026-financialstatements.htm","event_type":"periodic_interim","event_domain":"periodic","is_material":false,"confidence":0.95,"reasoning":"This exhibit is an unaudited condensed interim consolidated financial statement for the six months ended June 30, 2026, clearly labeled as such in the document header. It presents balance sheets, statements of operations, statements of changes in shareholders' equity, and cash flows for interim periods. This is a periodic financial report itself (not a discrete event or press release announcing results), and should be classified as periodic_interim per the taxonomy guidance that defers such reports for separate processing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:53:09.407530+00:00","company_name":"Cresco Labs Inc.","ticker":"CRLBF","filing_date":"2026-08-06"},{"id":26956,"accession_number":"0001832928-26-000010","item_number":"EX-99.2","item_title":"q22026mda.htm","event_type":"periodic_quarterly","event_domain":"periodic","is_material":false,"confidence":0.95,"reasoning":"This exhibit is a Management's Discussion and Analysis (MD\u0026A) accompanying unaudited condensed interim consolidated financial statements for the three and six months ended June 30, 2026 and 2025. The document explicitly states it is \"supplemental to, and should be read in conjunction with, the Company's unaudited condensed interim consolidated financial statements\" and covers a quarterly reporting period. This is a periodic quarterly financial report, not a discrete event or earnings release press announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:53:09.407530+00:00","company_name":"Cresco Labs Inc.","ticker":"CRLBF","filing_date":"2026-08-06"},{"id":26957,"accession_number":"0001832928-26-000010","item_number":"EX-99.3","item_title":"q22026pressrelease.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a quarterly earnings press release disclosing Q2 2026 financial results for Cresco Labs Inc., including revenue of $173 million, net income of $15 million, and Adjusted EBITDA of $40 million. The document explicitly states \"Cresco Labs Reports Second Quarter 2026 Financial Results\" and includes consolidated financial statements, cash flow data, and non-GAAP reconciliations typical of an earnings announcement. While the exhibit also mentions a CFO departure (Sharon Schuler stepping down), the primary and dominant disclosure is the quarterly financial results, making this an earnings_release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:53:09.407530+00:00","company_name":"Cresco Labs Inc.","ticker":"CRLBF","filing_date":"2026-08-06"}]}